Remote Lifestyle Coaching with Glucose Monitoring for Healthy Weight Gain in Pregnancy
Tests remote coaching with glucose monitoring in pregnant women with overweight or obesity.
Plain-language title generated from the registry record
Registry title: Continuous Glucose and E-Monitoring to Support Healthy Weight Gain in Pregnancies - The GEM Study
Key facts
- Where
- Little Rock, United StatesSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for pregnant women with overweight or obesity, expecting one baby, to test a remote lifestyle program with glucose monitoring.
- Age
- 18 to 45 years
- Sex
- Women only
- Disease stage
- Pregnant, less than 20 weeks of gestation, singleton pregnancy, BMI of 25 - 40 kg/m-2
- Earlier treatment
- Must not take medicines known to influence fetal growth, such as thyroid hormone, glucocorticoids, insulin or oral hypoglycemic agents. Must not have conceived with assisted fertility treatments.
Main reasons for not taking part
- Smoker
- Existing medical conditions that pregnancy might make worse, such as diabetes, kidney failure, high blood pressure or cancer
- Current mental health or eating disorder
- Contraindication to exercise
- Plans to move out of the state in the next 6 months
This trial only enrols pregnant participants. The registry sentence this rests on: pregnant women less than 20 weeks of gestation at time of screening
Read by machine on 12 November 2026.
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 45 years old?
Source: NCT06666257, who can take part
Where in United States
- Arkansas Children's Research Institute - Arkansas Children's Nutrition Center, University of Arkansas for Medical SciencesLittle Rock, United StatesContact: Elizabeth Hayes, Recruitment CoordinatorTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Arkansas Children's Hospital Research Institute
- Trial code
- NCT06666257
- Record updated
- 9 October 2026
- Original description
This single-arm pilot study will evaluate the feasibility and acceptability of a remotely delivered behavioral lifestyle intervention, adapted from the SmartMoms framework, to promote health gestational weight gain in pregnant women with overweight and obesity. Twelve to sixteen participants will receive weekly virtual motivational interview sessions with trained health coaches, review their daily weight data, step count, and continuous glucose monitoring data, and tailored guidance on physical activity and nutrition. Educational content will be delivered electronically, with peer support provided through a closed online group. A simulated (mock) control arm will be created post hoc from existing records for preliminary comparisons; all enrolled participants will receive the intervention.Read full original descriptionShow less
Continuous Glucose and E-Monitoring to Support Healthy Weight Gain in Pregnancies - The GEM Study
This single-arm pilot study will evaluate the feasibility and acceptability of a remotely delivered behavioral lifestyle intervention, adapted from the SmartMoms framework, to promote health gestational weight gain in pregnant women with overweight and obesity. Twelve to sixteen participants will receive weekly virtual motivational interview sessions with trained health coaches, review their daily weight data, step count, and continuous glucose monitoring data, and tailored guidance on physical activity and nutrition. Educational content will be delivered electronically, with peer support provided through a closed online group. A simulated (mock) control arm will be created post hoc from existing records for preliminary comparisons; all enrolled participants will receive the intervention.
Inclusion: pregnant women less than 20 weeks of gestation at time of screening; 18-45 years of age; BMI of 25 - 40 kg/m-2; Expecting a singleton pregnancy; Smartphone and/or reliable internet access; Willing to be identifiable to other study participants in the study program .
Exclusion: Contraindication to exercise (OB/GYN release is obtained prior to consent); Medications during pregnancy known to influence fetal growth (e.g., thyroid hormone, glucocorticoids, insulin, oral hypoglycemic agents); Preexisting medical conditions that might be exacerbated by pregnancy (e.g., diabetes mellitus, chronic renal failure, hypertension, malignancies, seizure disorder, lupus, drug or alcohol abuse, serious psychiatric disorders); Current mental health or eating disorder; Smoker; Conceived with assisted fertility treatments; Plans to move out of the state in the next 6 months following screening.
The formative phase (Phase I), classified as exempt by the institutional review board will seek participation from individuals meeting the following criteria:; Currently pregnant or pregnant within the past 36 months; Community partners with relevant perspectives to inform recruitment, adaptation approaches and feasibility of the phase 2 pilot trial; Clinical Trial (Phase 2).